The nonspecific symptoms of lichen sclerosus often lead to a missed or delayed diagnosis, exacerbating the challenges that patients with the condition face.
The handheld tool, intended for use by primary care physicians, uses spectroscopy and algorithms to evaluate skin lesions for potential cancer in a matter of seconds.
Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration had declined to approve its experimental therapy to treat a form of skin cancer following an.